Joanna Mangana

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers et al. · The Lancet Oncology · 2021 · 201 citations

Oncology, Anti-pd-1 Therapy, Melanoma +10

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma

C. Owen, Xue Bai, Serigne Lo et al. · Annals of Oncology · 2021 · 172 citations · Full text

Tumor Immunology, Melanoma, Immunology +6

Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages

Roman Huber, Barbara Meier, Atsushi Otsuka et al. · Scientific Reports · 2016 · 135 citations · Full text

Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research

Dimitri Gassmann, Stefan Weiler, Joachim C. Mertens et al. · Transplantation Direct · 2018 · 134 citations · Full text

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

C. Owen, Alexander N. Shoushtari, D Chauhan et al. · Annals of Oncology · 2020 · 106 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +7